Skip to main content
. 2017 Aug 12;8(45):78781–78795. doi: 10.18632/oncotarget.20227

Table 1. Comparison of cIAP2 expression in triple-negative breast cancer tissue microarrays using immunohistochemistry (IHC).

Interpretation TNBC TMA (N=100)
Quick score Frequency Percent
Negative (0) 0 4 4%
1 0
2 0
Weak/Moderate (1+) 3 20 52%
4 13
5 19
Strong (2+) 6 38 44%
7 6
8 0

The cIAP2-positive status was assigned for scores “1+” and “2+.”